Literature DB >> 2626603

Low current electrostimulation produces naloxone-reversible analgesia in rats.

M H Skolnick1, O B Wilson, R F Hamilton, C D Collard, L Hudson-Howard, C Hymel, D H Malin.   

Abstract

A new form of transcranial electrostimulation (TE) has been shown to induce analgesia in rats, as measured by the wet tail flick test. Charge-balanced rectangular current pulses of very low amplitude were delivered bilaterally into low impedance regions of the rat pinnae. The resultant analgesia was studied as a function of systematic variations in stimulus frequency, amplitude and duration. The optimal current for inducing analgesia was found to be 10 microA, well below the startle threshold, and several orders of magnitude below effective stimulus current levels required for other treatment modalities. The optimal stimulation duration was 30 min, during which time a slow onset of analgesia was noted. Significant analgesia persisted for at least 200 min after stimulation ended, and no evidence was found of tolerance developing in the course of 5 daily stimulation sessions. Consistent with findings for other forms of electrostimulation, the analgesic effect of TE was abolished by subcutaneous injection of 3 mg/kg naloxone, suggesting that the mechanism of TE analgesia has an endogenous opioid component.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2626603     DOI: 10.1159/000099527

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  2 in total

Review 1.  Analgesic effects of noninvasive brain stimulation in rodent animal models: a systematic review of translational findings.

Authors:  Magdalena Sarah Volz; Theresa Sophie Volz; Andre Russowsky Brunoni; João Paulo Vaz Tostes Ribeiro de Oliveira; Felipe Fregni
Journal:  Neuromodulation       Date:  2012-07-03

Review 2.  The Contribution of Endogenous Modulatory Systems to TMS- and tDCS-Induced Analgesia: Evidence from PET Studies.

Authors:  Marcos F DosSantos; Aleli T Oliveira; Natália R Ferreira; Antônio C P Carvalho; Paulo Henrique Rosado de Castro
Journal:  Pain Res Manag       Date:  2018-11-13       Impact factor: 3.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.